Cargando…

Updates of incretin‐related drugs for the treatment of type 2 diabetes

Mechanisms of dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide‐1 receptor agonists and glucagon‐like peptide‐1 receptor/glucose‐dependent insulinotropic polypeptide receptor dual‐agonist in glycemic control and/or weight loss.[Image: see text]

Detalles Bibliográficos
Autores principales: Araki, Hirotaka, Matsumura, Takeshi, Furukawa, Noboru, Araki, Eiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889679/
https://www.ncbi.nlm.nih.gov/pubmed/36373430
http://dx.doi.org/10.1111/jdi.13945

Ejemplares similares